This study analyzed patients with acute ischemic stroke and evaluated the risk of developing symptomatic intracerebral hemorrhage (sICH) after the administration of thrombolytic treatment. Patients were studied using data obtained retrospectively from a previous multi-center prospective trial. In total, 645 patients with anterior circulation strokes were studied. All patients received intravenous or intra-arterial thrombolysis within 6 h of symptom onset. Patients were divided into three pre-treatment groups based on magnetic resonance diffusion-weighted imaging (DWI) stroke lesion size: 1) small (< 10 mL), 2) moderate (10–100 mL), and 3) large (> 100 mL). Of the 645 patients studied, 44 (6.8%) developed sICH after thrombolysis. There was a significant difference of sICH in the three pre-treatment groups, with rates of 2.8%, 7.8%, and 16.1% in patients with small, moderate, and large DWI stroke lesions, respectively (p < 0.05). In addition, pre-treatment DWI lesion size was an independent risk factor for potential sICH when evaluating multiple factors with logistic regression analysis. The authors concluded that DWI lesion size is an important risk factor for the development of sICH after thrombolysis in acute stroke and that thrombolytics should be used judiciously in patients with large DWI lesions.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Emergency Medicine
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2008 Elsevier Inc. Published by Elsevier Inc. All rights reserved.